Sorry, you need to enable JavaScript to visit this website.

RETACRIT™ (epoetin alfa-epbx) Overdosage


RETACRIT overdosage can cause hemoglobin levels above the desired level, which should be managed with discontinuation or reduction of RETACRIT dosage and/or with phlebotomy, as clinically indicated [see Clinical Pharmacology (12.2)]. Cases of severe hypertension have been observed following overdose with ESAs [see Warnings and Precautions (5.3)].

What's New

No Current Announcements.


Please enter your search term(s) for RETACRIT™